Every article on this site is written by AI from official sources and checked by a second AI. How it works
Proposed rule

Global Benchmark for Efficient Drug Pricing (GLOBE) Model

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Dec. 23, 2025. Document 2025-23702. Updated Nov. 16, 2026.

What it does

This proposed rule proposes to implement the Global Benchmark for Efficient Drug Pricing Model ("GLOBE Model"), a new Medicare payment model under section 1115A of the Social Security Act (the Act). The GLOBE Model would test whether a payment model that uses an alternative method for calculating Part B inflation rebate amounts for certain separately payable Part B drugs and biologicals products reduces costs for Medicare fee-for-service (FFS) beneficiaries and the Medicare program while preserving quality of care.

The Centers for Medicare & Medicaid Services's summary, as published in the Federal Register.

What it would change

1 part of Title 42 of the Code of Federal Regulations:

42 CFR 513

Before this

No earlier Federal Register document under regulation identifier 0938-AV66 since Jan. 1, 2025.

Since then:

What happens next and when

To be assured consideration, comments must be received at one of the addresses provided below, by February 23, 2026.

The agency's dates, word for word.

Document number2025-23702
ActionProposed rule.
AgenciesHealth and Human Services Department; Centers for Medicare & Medicaid Services
PublishedDec. 23, 2025
Comments closeFeb. 23, 2026
Regulation identifier (RIN)0938-AV66
DocketCMS-2025-1889
Significant (marked in the Federal Register)Yes

Source: the Federal Register (public domain). The document in the Federal Register